Sakai Hiromi, Hisamoto Shuji, Fukutomi Ippei, Sou Keitaro, Takeoka Shinji, Tsuchida Eishun
Advanced Research Institute for Science and Engineering, Waseda University, Tokyo 169-8555, Japan.
J Pharm Sci. 2004 Feb;93(2):310-21. doi: 10.1002/jps.10525.
A method to quantitatively measure the bacterial endotoxin content (lipopolysaccharide, LPS) in phospholipid vesicles or liposomes is necessary because the conventional Limulus amebocyte lysate (LAL) test does not provide an accurate measurement due to the hydrophobic interaction of LPS and vesicles that shields the activity of LPS to clot the LAL coagulant. This interference was evident from isothermal titration calorimetry results in our study that clearly demonstrated the insertion of the LPS molecule into the phospholipid bilayer membrane. Hemoglobin-vesicles (HbVs; particle diameter = 251 +/- 80 nm; [Hb] = 10 g/dL) are artificial oxygen carriers encapsulating a conc. Hb solution in phospholipid vesicles, and their oxygen transporting ability has been extensively studied. To accurately measure the LPS content in the HbV suspension, we tested the solubilization of HbV with deca(oxyethylene) dodecyl ether (C(12)E(10)), used to release the LPS entrapped in the vesicles, as a pretreatment for the succeeding LAL assay of the kinetic-turbidimetric gel clotting (detecting wavelength, 660 nm). The C(12)E(10) surfactant interferes with the gel clotting in a concentration-dependent manner, and the optimal condition was determined in terms of minimizing the dilution factor and C(12)E(10) concentration. We clarified the condition that allowed the measurement of LPS at >0.1 endotoxin units (EU)/mL in the HbV suspension. Moreover, the utilization of histidine-immobilized agarose gel effectively concentrated the trace amount of LPS from the C(12)E(10)-solubilized HbV solution and washed out C(12)E(10) as an inhibitory element. The LAL assay with the LPS-adsorbed gel resulted in the detection limit of 0.0025 EU/mL. Pretreatment with C(12)E(10) would be applicable not only to HbVs but also to other drug delivery systems using phospholipid vesicles encapsulating or incorporating functional molecules.
由于脂多糖(LPS)与脂质体之间的疏水相互作用会屏蔽LPS使鲎试剂凝固的活性,导致传统的鲎试剂(LAL)检测无法提供准确的测量结果,因此需要一种定量测量磷脂囊泡或脂质体中细菌内毒素含量(脂多糖,LPS)的方法。在我们的研究中,等温滴定量热法结果清楚地表明LPS分子插入磷脂双分子层膜中,这种干扰很明显。血红蛋白囊泡(HbV;粒径 = 251±80 nm;[Hb] = 10 g/dL)是将浓缩血红蛋白溶液包裹在磷脂囊泡中的人工氧载体,其氧运输能力已得到广泛研究。为了准确测量HbV悬浮液中的LPS含量,我们测试了用十二烷基十聚氧乙烯醚(C(12)E(10))溶解HbV,用于释放包裹在囊泡中的LPS,作为后续动力学比浊凝胶凝固LAL检测(检测波长660 nm)的预处理。C(12)E(10)表面活性剂以浓度依赖的方式干扰凝胶凝固,根据最小化稀释因子和C(12)E(10)浓度确定了最佳条件。我们明确了在HbV悬浮液中测量>0.1内毒素单位(EU)/mL LPS的条件。此外,利用固定化组氨酸的琼脂糖凝胶有效地从C(12)E(10)溶解的HbV溶液中浓缩痕量LPS,并洗去作为抑制元素的C(12)E(10)。用吸附LPS的凝胶进行LAL检测的检测限为0.0025 EU/mL。用C(12)E(10)进行预处理不仅适用于HbV,也适用于其他使用包裹或掺入功能分子的磷脂囊泡的药物递送系统。